This protocol describes the use of Cas9 ribonucleoproteins and AAV6 donor templates to enable precise genome editing of human hematopoietic stem cells by homologous recombination (HR), including in vitro and in vivo assays for determining HR frequencies in HSPCs.
- Rasmus O Bak
- Daniel P Dever
- Matthew H Porteus